Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

262

HTML

2337

Figures (1-2)

104

Tables (1-1)

114

Sum=2817

Feb 7, 2005 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. Feb 7, 2005; 11(5): 645-648
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.645

Table 1 Sensitivity of CEA and TPA-M in patients with colorectal cancer according to the staging of the TNM classification.

	Sensitivity at different stages (%)
	I	II	III	IV
CEA	35	23.3	34.1	69
TPA-M	75	53.3	61	82.8
Increased CEA or TPA-M	77.5	60	68.3	91.4

Citation: Fernandes LC, Kim SB, Matos D. Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma. World J Gastroenterol 2005; 11(5): 645-648
URL: https://www.wjgnet.com/1007-9327/full/v11/i5/645.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i5.645